Immunogenicity and Safety Study of the 13-valent Pneumococcal Polysaccharide Conjugate Vaccine in 2-71 Months Old Healthy Infants and Toddlers (the Youngest Could be 6 Weeks Old)
Clinical trial NCT02736240 · COMPLETED
Trial details
- NCT number
- NCT02736240
- Sponsor
- Walvax Biotechnology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-08
- Primary completion
- 2017-12-03
- Enrollment
- 2760
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.